妊娠相关血浆蛋白A作为甲状腺眼病潜在治疗靶点
研究从19例甲状腺眼病患者采集眶周组织分离成纤维细胞,发现促炎细胞因子显著增加PAPP-A表达而不影响IGF-IR表达;抑制PAPP-A蛋白水解活性可抑制眶成纤维细胞中IGF-IR活化,CD34+细胞约占培养细胞80%并贡献约70%的PAPP-A和IGF-IR表达。
要点
- 促炎细胞因子显著增加甲状腺眼病成纤维细胞中PAPP-A表达。
- 抑制PAPP-A蛋白水解活性可抑制甲状腺眼病眶成纤维细胞中IGF-IR活化。
- CD34+甲状腺眼病成纤维细胞约占培养细胞80%,贡献约70%的PAPP-A和IGF-IR表达细胞。
核心结论
- 结果支持PAPP-A在甲状腺眼病发病机制中发挥作用,并提示靶向IGF轴的新型治疗潜力。
研究设计与样本
- 从19例接受手术的甲状腺眼病患者采集眶周组织,进行成纤维细胞分离与培养。
- 手术在Mayo Clinic手术室进行,细胞培养在无菌组织培养设施中进行。
- 用促炎细胞因子处理甲状腺眼病成纤维细胞,流式分选CD34-和CD34+眶成纤维细胞。
- 检测PAPP-A表达与蛋白水解活性、IGF-I刺激磷脂酰肌醇3激酶/Akt通路及抗PAPP-A免疫中和抗体的抑制作用。
主要发现
- 促炎细胞因子显著增加甲状腺眼病成纤维细胞中PAPP-A表达,而IGF-IR表达不受细胞因子处理影响。
- 抑制PAPP-A蛋白水解活性可抑制甲状腺眼病患者眶成纤维细胞中IGF-IR活化。
- CD34+甲状腺眼病成纤维细胞约占培养细胞的80%,并占表达PAPP-A和IGF-IR细胞的约70%。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Proptosis in thyroid eye disease (TED) can result in facial disfigurement and visual dysfunction. Treatment with insulin-like growth factor I receptor (IGF-IR) inhibitors has been shown to be effective in reducing proptosis but with side effects. OBJECTIVE: To test the hypothesis that inhibition of IGF-IR indirectly and more selectively with PAPP-A inhibitors attenuates IGF-IR signaling in TED. Informed consent was obtained from patients with TED undergoing surgery, and retro-orbital tissue was collected for fibroblast isolation and culture. Operations were performed in Mayo Clinic operating suites. Cell culture was performed in a sterile tissue culture facility. Retro-orbital tissue was collected from 19 patients with TED. METHODS: Treatment of TED fibroblasts with proinflammatory cytokines. Flow separation of CD34- and CD34+ orbital fibroblasts, the latter representing infiltrating fibrocytes into the orbit in TED. PAPP-A expression and proteolytic activity, IGF-I stimulation of phosphatidylinositol 3 kinase/Akt pathway, and inhibition by immuno-neutralizing antibodies against PAPP-A, CD34+ status, and associated PAPP-A and IGF-IR expression were measured. RESULTS: Proinflammatory cytokines markedly increased PAPP-A expression in TED fibroblasts. IGF-IR expression was not affected by cytokine treatment. Inhibition of PAPP-A's proteolytic activity suppressed IGF-IR activation in orbital fibroblasts from patients with TED. TED fibroblasts that were CD34+ represented ∼80% of the cells in culture and accounted for ∼70% of PAPP-A and IGF-IR-expressing cells. CONCLUSION: These results support a role for PAPP-A in TED pathogenesis and indicate the potential for novel therapeutic targeting of the IGF axis.
引用
- Conover CA, Bale LK, Stan MN, et al. PAPP-A as a Potential Target in Thyroid Eye Disease. J Clin Endocrinol Metab. 2024. PMID: 38752390. doi:10.1210/clinem/dgae339
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。